Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Net-Interest-Income" stands at -868.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2022.
Novartis AG's third quarter result of -301.00 Million USD for the item "Net Interest Income" represents an increase of 8.79 percent compared to it's second quarter result.
Also, Novartis AG's third quarter result of -301.00 Million USD for the item "Net Interest Income" represents a decrease of -26.47 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -868.00 Million USD for the item "Net Interest Income" represents a decrease of -7.83 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -259.00 Million United States Dollars compared to the value the year prior.
The 1 year change is -259.00 Million United States Dollars.
The 3 year change is -24.00 Million United States Dollars.
The 5 year change is -93.00 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Interest Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Interest Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Interest Income | 280,205,508,085.11 |